Chaozhao Liang

Molecular classifications of prostate cancer: basis for individualized risk stratification and precision therapy

Jialin Meng, Meng Zhang, Z. Hao, 2023, Annals of medicine.

Multiomics characterization and verification of clear cell renal cell carcinoma molecular subtypes to guide precise chemotherapy and immunotherapy

Jialin Meng, Jun Zhou, Z. Hao, 2023, iMeta.

Characterizing CD8+ TEMRA Cells in CP/CPPS Patients: Insights from Targeted Single-Cell Transcriptomic and Functional Investigations

Jialin Meng, Qintao Ge, Chaozhao Liang, 2024, ImmunoTargets and therapy.

Insights from Immunomics and Metabolomics on the Associations between Prostatic Diseases and COVID-19

Qintao Ge, Feixiang Yang, Chaozhao Liang, 2024, Prostate International.

Integrated analysis of histone modification features in clear cell renal cancer for risk stratification and therapeutic prediction.

Jialin Meng, Li Zhang, Qintao Ge, 2024, Translational oncology.